These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 25569740

  • 21. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.
    Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp J, Lakatos L.
    World J Gastroenterol; 2009 Jul 28; 15(28):3504-10. PubMed ID: 19630105
    [Abstract] [Full Text] [Related]

  • 22. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.
    Guo J, Chen BL, Chen ZH, Luo XP, Qiu Y, Zhang SH, Feng R, He Y, Zeng ZR, Song XM, Ben-Horin S, Mao R, Chen MH.
    J Gastroenterol Hepatol; 2018 Mar 28; 33(3):608-614. PubMed ID: 28804920
    [Abstract] [Full Text] [Related]

  • 23. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
    Tozer P, Ng SC, Siddiqui MR, Plamondon S, Burling D, Gupta A, Swatton A, Tripoli S, Vaizey CJ, Kamm MA, Phillips R, Hart A.
    Inflamm Bowel Dis; 2012 Oct 28; 18(10):1825-34. PubMed ID: 22223472
    [Abstract] [Full Text] [Related]

  • 24. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L.
    J Crohns Colitis; 2016 Jan 28; 10(1):55-60. PubMed ID: 26520164
    [Abstract] [Full Text] [Related]

  • 25. Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease.
    Toh JWT, Wang N, Young CJ, Rickard MJFX, Keshava A, Stewart P, Kariyawasam V, Leong R, and the Sydney IBD Cohort Collaborators.
    Dis Colon Rectum; 2018 Jan 28; 61(1):67-76. PubMed ID: 29215479
    [Abstract] [Full Text] [Related]

  • 26. Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades.
    Gonczi L, Lakatos L, Golovics PA, Angyal D, Balogh F, Ilias A, Pandur T, David G, Erdelyi Z, Szita I, Lakatos PL.
    Aliment Pharmacol Ther; 2024 Mar 28; 59(5):656-665. PubMed ID: 38115207
    [Abstract] [Full Text] [Related]

  • 27. Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
    Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N, Parmentier AL, Peyrin-Biroulet L, Vuitton L, GETAID BioLAP Study Group.
    Aliment Pharmacol Ther; 2020 Apr 28; 51(7):719-727. PubMed ID: 32080886
    [Abstract] [Full Text] [Related]

  • 28. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease.
    Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W.
    Aliment Pharmacol Ther; 2003 Dec 28; 18(11-12):1113-20. PubMed ID: 14653831
    [Abstract] [Full Text] [Related]

  • 29. Early Thiopurines Versus Conventional Step-Care Therapy for Modifying the Disease Course of Early Crohn's Disease: A Tertiary Referral Center Cohort Study.
    Qiu Y, Chen BL, Mao R, Zhang SH, He Y, Zeng ZR, Chen MH.
    Medicine (Baltimore); 2015 Aug 28; 94(31):e1148. PubMed ID: 26252273
    [Abstract] [Full Text] [Related]

  • 30. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G.
    Am J Gastroenterol; 2010 May 28; 105(5):1158-64. PubMed ID: 20010925
    [Abstract] [Full Text] [Related]

  • 31. The role of thiopurines in reducing the need for surgical resection in Crohn's disease: a systematic review and meta-analysis.
    Chatu S, Subramanian V, Saxena S, Pollok RC.
    Am J Gastroenterol; 2014 Jan 28; 109(1):23-34; quiz 35. PubMed ID: 24322839
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
    Golovics PA, Lakatos PL, Dávid G, Pandur T, Erdélyi Z, Horváth A, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Lovász BD, Szathmári M, Kiss LS, Lakatos L.
    Orv Hetil; 2012 Apr 08; 153(14):541-52. PubMed ID: 22450143
    [Abstract] [Full Text] [Related]

  • 34. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
    Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP.
    Gut; 2005 Feb 08; 54(2):237-41. PubMed ID: 15647188
    [Abstract] [Full Text] [Related]

  • 35. Faecal diversion in the management of perianal Crohn's disease.
    Hong MK, Craig Lynch A, Bell S, Woods RJ, Keck JO, Johnston MJ, Heriot AG.
    Colorectal Dis; 2011 Feb 08; 13(2):171-6. PubMed ID: 19863597
    [Abstract] [Full Text] [Related]

  • 36. Perianal Crohn's disease findings other than fistulas in a population-based cohort.
    Peyrin-Biroulet L, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ.
    Inflamm Bowel Dis; 2012 Jan 08; 18(1):43-8. PubMed ID: 21351216
    [Abstract] [Full Text] [Related]

  • 37. Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience.
    Suárez Ferrer C, González-Lama Y, González-Partida I, Calvo Moya M, Vera Mendoza I, Matallana Royo V, Arevalo Serrano J, Abreu Garcia L.
    Dig Dis Sci; 2019 Mar 08; 64(3):875-879. PubMed ID: 30542812
    [Abstract] [Full Text] [Related]

  • 38. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease.
    Keljo DJ, Markowitz J, Langton C, Lerer T, Bousvaros A, Carvalho R, Crandall W, Evans J, Griffiths A, Kay M, Kugathasan S, LeLeiko N, Mack D, Mamula P, Moyer MS, Oliva-Hemker M, Otley A, Pfefferkorn M, Rosh J, Hyams JS.
    Inflamm Bowel Dis; 2009 Mar 08; 15(3):383-7. PubMed ID: 19023863
    [Abstract] [Full Text] [Related]

  • 39. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 08; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 40. Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.
    Göttgens KW, Jeuring SF, Sturkenboom R, Romberg-Camps MJ, Oostenbrug LE, Jonkers DM, Stassen LP, Masclee AA, Pierik MJ, Breukink SO.
    Eur J Gastroenterol Hepatol; 2017 May 08; 29(5):595-601. PubMed ID: 28350751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.